β-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: Involvement of the p38MAPK pathway

Neurobiology of Disease

Volumn 11, Issue 2, 2002, Pages 257-274

  Giovannini, Maria Grazia ^a   Scali, Carla ^a   Prosperi, Costanza ^a   Bellucci, Arianna ^a   Vannucchi, Maria Giuliana ^a   Rosi, Susanna ^a   Pepeu, Giancarlo ^a   Casamenti, Fiorella ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alzheimer's disease; Cholinergic hypofunction; COX 2; Inflammation; MAPK; Microglia; Rofecoxib; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; ROFECOXIB; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL INFILTRATION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ENCEPHALITIS; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME LOCALIZATION; INFLAMMATION; MALE; MICROGLIA; NERVE CELL STIMULATION; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OLIVARY NUCLEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 0036968944     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0538     Document Type: Article

References (67)

1. Adderley, S. R., & Fitzgerald, D. J. (1999) Oxidative damage of cardiomyocytes is limited by extracellular regulated kinase 1-2-mediated induction of cyclooxygenase-2. J. Biol. Chem. 274, 5038-5046.
2. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G. M., Cooper, N. R., Eikelenboom, P., Emmerling, M., Fiebich, B. L., Finch, C. E., Frautschy, S., Griffin, W. S., Hampel, H., Hull, M., Landreth, G., Lue, L., Mrak, R., Mackenzie, I. R., McGeer, P. L., O'Banion, M. K., Pachter, J., Pasinetti, G., Plata-Salaman, C., Rogers, J., Rydel, R., Shen, Y., Streit, W., Strohmeyer, R., Tooyoma, I., van Muiswinkel, F. L., Veerhuis, R., Walker, D., Webster, S., Wegrzyniak, B., Wenk, G., & Wyss-Coray, T. (2000) Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383-421.
3. Barry, O. P., Kazanietz, M. G., Pratico, D., & FitzGerald, G. A. (1999) Arachidonic acid in platelet microparticles up-regulates cyclooxygenase- 2-dependent prostaglandin formation via a protein kinase C/mitogen- activated protein kinase-dependent pathway. J. Biol. Chem. 274, 7545-7556.
4. Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-417.
5. Bellmann, K., Burkart, V., Bruckhoff, J., Kolb, H., & Landry, J. (2000) p38-dependent enhancement of cytokine-induced nitric-oxide synthase gene expression by heat shock protein 70. J. Biol. Chem. 275, 18172-18179.
6. Bhat, N. R., Zhang, P., Lee, J. C., & Hogan, E. L. (1998) Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18, 1633-1641.
7. Breder, C. D., Dewitt, D., & Kraig, R. P. (1995) Characterization of inducible cyclooxygenase in rat brain. J. Comp. Neurol. 355, 296-315.
8. Breitner, J. C. S., Welsh, K. A., Helms, M. J., Gaskell, P. C., Gau, B. A., Roses, A. D., Pericak-Vance, M. A., & Saunders, A. M. (1995) Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol. Aging 16, 523-530.
9. Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) In-vivo measurement of activated microglia in dementia. Lancet 358, 461-467.
10. Casamenti, F., Prosperi, C., Scali, C., Giovannelli, L., Colivicchi, M. A., Faussone-Pellegrini, M. S., & Pepeu, G. (1999) Interleukin-1b activates forebrain glial cells and increases nitric oxide production and cortical glutamate and gamma-aminobutyric acid release in vivo: Implications for Alzheimer's disease. Neuroscience 91, 831-842.
11. Chan, C. C., Boyce, S., Brideau, C., Charleson, S., Cromlish, W., Ethier, D., Evans, J., Ford-Hutchinson, A. W., Forrest, M. J., Gauthier, J. Y., Gordon, R., Gresser, M., Guay, J., Kargman, S., Kennedy, B., Leblanc, Y., Leger, S., Mancini, J., O'Neill, G. P., Ouellet, M, Patrick, D., Percival, M. D., Perrier, H., Prasit, P., Rodger, I., Tagari, P., Therien, M., Vickers, P., Visco, D., Wang, Z., Webb, J., Wong, E., XU, L. J., Young, R. N., Zamboni, R., & Riendeau, D. (1999) Rofecoxib (Vioxx, MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone): A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J. Pharmacol. Exp. Ther. 290, 551-560.
12. Chao, C. C., Hu, S., Sheng, W. S., Bu, D., Bukrinsky, M. I., & Peterson, P. K. (1996) Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia 16, 276-284.
13. Chen, B., Chen, Y., & Lin, W. (1999) Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages. Immunology 97, 124-129.
14. Combs, C. K., Johnson, D. E., Cannady, S. B., Lehman, T. M., & Landreth, G. E. (1999) Identification of microglia signal trasduction pathways mediating a neurotoxic response to amyloidogenic fragments of b-amyloid and prion protein. J. Neurosci. 19, 928-939.
15. Da Silva, J., Pierrat, B., Mary, J. L., & Lesslauer, W. (1997) Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J. Biol. Chem. 272, 28373-28380.
16. Dean, J. L., Brook, M., Clark, A. R., & Saklatvala, J. (1999) p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274, 264-269.
17. Dineley, K. T., Westerman, M., Bui, D., Bell, K., Ashe, K. H., & Sweatt, J. D. (2001) Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci. 21, 4125-4133.
18. El Khoury, J., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) Scavenger receptor-mediated adhesion of microglia to b-amyloid fibrils. Nature 382, 716-719.
19. Faour, W. H., He, Y., He, Q. W., de Ladurantaye, M., Quintero, M., Mancini, A., & Di Battista, J. A. (2001) Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts. J. Biol. Chem. 276, 31720-31731.
20. Fiebich, B. L., Mueksch, B., Boehringer, M., & Hull, M. (2000) Interleukin-1beta induces cyclooxygenase-2 and prostaglandin E(2) synthesis in human neuroblastoma cells: Involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB. J. Neurochem. 75, 2020-2028.
21. FitzGerald, G. A., & Patrono, C. (2001) The coxibs, selective inhibitors of cyclooxygenase-2. N. Engl. J. Med. 345, 433-442.
22. Ghatan, S., Larner, S., Kinoshita, Y., Hetman, M., Patel, L., Xia, Z., Youle, R. J., & Morrison, R. S. (2000) p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J. Cell Biol. 150, 335-347.
23. Giovannelli, L., Casamenti, F., Scali, C., Bartolini, L., & Pepeu, G. (1995) Differential effects of amyloid peptides b-(1-40) and b-(25-35) injections into the rat nucleus basalis. Neuroscience 66, 781-792.
24. Giovannelli, L., Scali, C., Faussone-Pellegrini, M. S., Pepeu, G., & Casamenti, F. (1998) Long-term changes in the aggregation state and toxic effects of b-amyloid injected into the rat brain. Neuroscience 87, 349-357.
25. Giovannini, M. G. (2002) Double-label confocal microscopy of phosphorylated protein kinases involved in long-term potentiation. Methods Enzymol. 345, 426-436.
26. Giovannini, M. G., Blitzer, R. D., Wong, T., Asoma, K., Tsokas, P., Morrison, J. H., Iyengar, R., & Landau, E. M. (2001) Mitogen-activated protein kinase regulates early phosphorylation and delayed expression of Ca2+/calmodulin-dependent protein kinase II in long-term potentiation. J. Neurosci. 21, 7053-7062.
27. Giovannini, M. G., Mutolo, D., Bianchi, L., Michelassi, A., & Pepeu, G. (1994) NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: A microdialysis study. J. Neurosci. 14, 1358-1365.
28. Goldgaber, D., Harris, H. W., Hla, T., Maciag, T., Donnelly, R. J., Jacobsen, J. S., Vitek, M. P., & Gajdusek, D. C. (1989) Interleukin I regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. USA 86, 7606-7610.
29. Gonzalez-Scarano, F., & Baltuch, G. (1999) Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22, 219-240.
30. Griffin, W. S., Sheng, J. G., Royston, M. C., Gentleman, S. M., McKenzie, J. E., Graham, D. I., Roberts, G. W., & Mrak, R. E. (1998) Glial-neuronal interactions in Alzheimer' disease: The potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 8, 65-72.
31. Guan, Z., Baier, L. D., & Morrison, A. R. (1997) p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1beta. J. Biol. Chem. 272, 8083-8089.
32. Guan, Z., Buckman, S. Y., Pentland, A. P., Templeton, D. J., & Morrison, A. R. (1998) Induction of cyclooxygenase-2 by the activated MEKK1→SEK1/MKK4→p38 mitogen-activated protein kinase pathway. J. Biol. Chem. 273, 12901-12908.
33. Han, O. J., Joe, K. H., Kim, S. W., Lee, H. S., Kwon, N. S., Baek, K. J., & Yun, H. Y. (2001) Involvement of p38 mitogen-activated protein kinase and apoptosis signal-regulating kinase-1 in nitric oxide-induced cell death in PC12 cells. Neurochem. Res. 26, 525-532.
34. Hensley, K., Floyd, R. A., Zheng, N. Y., Nael, R., Robinson, K. A., Nguyen, X., Pye, Q. N., Stewart, C. A., Geddes, J., Markesbery, W. R., Patel, E., Johnson, G. V., & Bing, G. (1999) p38 kinase in activated in the Alzheimer's disease brain. J. Neurochem. 72, 2053-2058.
35. Ho, L., Pieroni, C., Winger, D., Purhoit, D. P., Aisen, P. S., & Pasinetti, G. M. (1999) Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease. J. Neurosci. Res. 57, 295-303.
36. Hu, S., Ali, H., Sheng, W. S., Ehrlich, L. C., Peterson, P. K., & Chao, C. C. (1999) Gp-41-mediated astrocyte inducible nitric oxide synthase mRNA expression: Involvement of interleukin-1beta production by microglia. J. Neurosci. 19, 6468-6474.
37. Hull, M., Lieb, K., & Fiebich, B. L. (2002) Pathways of inflammatory activation in Alzheimer's disease: Potential targets for disease modifying drugs. Curr. Med. Chem. 9, 83-88.
38. LaPointe, M. C., & Isenovic, E. (1999) Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension 33, 276-282.
39. Lasa, M., Mahtani, K. R., Finch, A., Brewer, G., Saklatvala, J., & Clark, A. R. (2000) Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol. Cell. Biol. 20, 4265-4274.
40. Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Heys, J. R., & Landvatter, S. W. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746.
41. Lewis, A. J., & Manning, A. M. (1999) New targets for anti-inflammatory drugs. Curr. Opin. Chem. Biol. 3, 489-494.
42. Lorton, D. (1997) Beta-amyloid-induced IL-1 beta release from an activated human monocyte cell line is calcium- and G-protein-dependent. Mech. Ageing Dev. 94, 199-211.
43. Mackenzie, I. R., Hao, C., & Munoz, D. G. (1995) Role of microglia in senile plaque formation. Neurobiol. Aging 16, 797-804.
44. McCann, S. M. (1997) The nitric oxide hypothesis of brain aging. Exp. Gerontol. 32, 431-440.
45. McDonald, D. R., Brunden, K. R., & Landreth, G. E. (1997) Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci. 17, 2284-2294.
46. McGeer, E. G., & McGeer, P. L. (1998) The importance of inflammatory mechanisms in Alzheimer disease. Exp. Gerontol. 33, 371-378.
47. Mollace, V., & Nisticò, G. (1995) Release of nitric oxide from astroglial cells-A key mechanism in neuroimmune disorders. Adv. Neuroimmunol. 5, 421-430.
48. Murphy, S. (2000) Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia 29, 1-13.
49. Paccani, S. R., Boncristiano, M., Ulivieri, C., D'Elios, M. M., Del Prete, G., & Baldari, C. T. (2002) Nonsteroidal anti-inflammatory drugs suppress T-cell activation by inhibiting p38 MAPK induction. J. Biol. Chem. 277, 1509-1513.
50. Pasinetti, G. M., & Aisen, P. S. (1998) Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 87, 319-324.
51. Paxinos, G., & Watson, G. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
52. Pyo, H., Jou, I., Jung, S., Hong, S., & Joe, E. H. (1998) Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia. NeuroReport 9, 871-874.
53. Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270, 7420-7426.
54. Reynolds, C. H., Nebrcda, A. R., Gibb, G. M., Utton, M. A., & Anderton, B. H. (1997) Reactivating kinase/p38 phosphorylates tau protein in vitro. J. Neurochem. 69, 191-198.
55. Rogers, J., Scott, W., Lue, L. F., Brachova, L., Civin, W. H., Emmerling, M., Shivers, B., Walker, D., & McGeer, P. L. (1996) Inflammation and Alzheimer's disease pathogenesis. Neurobiol. Aging 17, 681-686.
56. Rothwell, N. J., & Luheshi, G. N. (2000) Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23, 618-625.
57. Scali, C., Prosperi, C., Giovannelli, L., Bianchi, L., Pepeu, G., & Casamenti, F. (1999) β(1-40) amyloid peptide injection into the nucleus basalis of rats induces microglia reaction and enhances cortical gamma-aminobutyric acid release in vivo. Brain Res. 831, 319-321.
58. Scali, C., Prosperi, C., Vannucchi, M. G., Pepeu, G., & Casamenti, F. (2000) Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: Implication in Alzheimer's disease. Eur. J. Neurosci. 12, 1900-1912.
59. Shen, Y., Lue, L., Yang, L., Roher, A., Kuo, Y., Strohmeyer, R., Goux, W. J., Lee, V., Johnson, G. V., Webster, S. D., Cooper, N. R., Bradt, B., & Rogers, J. (2001) Complement activation by neurofibrillary tangles in Alzheimer's disease. Neurosci. Lett. 305, 165-168.
60. Sheng, J. G., Jones, R. A., Zhou, X. Q., McGinness, J. M., Van Eldik, L. J., Mrak, R. E., & Griffin, W. S. (2001) Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: Potential significance for tau protein phosphorylation. Neurochem. Int. 39, 341-348.
61. Smits, H. A., de Vos, N. M., Wat, J. W., van der, B. T., Verhoef, J., & Nottet, H. S. (2001) Intracellular pathways involved in TNF-alpha and superoxide anion release by Abeta(1-42)-stimulated primary human macrophages. J. Neuroimmunol. 115, 144-151.
62. Tan, J., Town, T., Mori, T., Wu, Y., Saxe, M., Crawford, F., & Mullan, M. (2000) CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. J. Neurosci. 20, 7587-7594.
63. Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., Kang, D. E., Marquez-Sterling, N., Golde, T. E., & Koo, E. H. (2001) A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414, 212-216.
64. Weldon, D. T., Rogers, S. D., Ghilardi, J. R., Finke, M. P., Cleary, J. P., O'Hare, E., Esler, W. P., Maggio, J. E., & Mantyh, P. W. (1998) Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J. Neurosci. 18, 2161-2173.
65. Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & Delong, M. R. (1981) Alzheimer's Disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10, 122-126.
66. Widmann, C., Gibson, S., Jarpe, M. B., & Johnson, G. L. (1999) Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol. Rev. 79, 143-180.
67. Wood, J., & Zinmaister, P. (1991) Tyrosine phosphorylation systems in Alzheimer's disease pathology. Neurosci. Lett. 121, 12-16.